Oral ibuprofen cost effective in neonates with patent ductus arteriosis

    This is a preview of subscription content, access via your institution.

    Notes

    1. 1.

      2019/2020 US dollars

    Reference

    1. Abushanab D, et al. Cost-effectiveness of Oral Versus Intravenous Ibuprofen Therapy in Preterm Infants With Patent Ductus Arteriosus in the Neonatal Intensive Care Setting: A Cohort-based Study. Clinical Therapeutics : 8 Jan 2021. Available from: URL: http://doi.org/10.1016/j.clinthera.2020.12.004

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Oral ibuprofen cost effective in neonates with patent ductus arteriosis. PharmacoEcon Outcomes News 870, 19 (2021). https://doi.org/10.1007/s40274-021-7422-8

    Download citation